JZL 184

CAS : 1101854-58-3

Ref. 3D-BJ180308

Informations sur le produit

• Nom: JZL 184
• CAS: 1101854-58-3

Description

JZL 184 is a drug that inhibits the enzyme monoacylglycerol lipase, which is involved in the production of endocannabinoids. This inhibition leads to decreased levels of 2-arachidonoylglycerol and monoacylglycerol. JZL 184 also inhibits the synthesis of proinflammatory cytokines and chemokines, leading to decreased inflammation. JZL 184 has been shown to have anti-cancer effects in mice by inhibiting tumor growth and metastasis through toll-like receptor 4 (TLR4) activation. It has also been shown to inhibit the production of inflammatory molecules and tumor necrosis factor alpha (TNFα) in cancer cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 520.14818
• Formule: C₂₇H₂₄N₂O₉
• Degré de pureté: Min. 95%